Literature DB >> 7295474

The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.

R Zaman, D B Jack, M J Kendall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7295474      PMCID： PMC1401814          DOI： 10.1111/j.1365-2125.1981.tb01239.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.

Authors:  P J Meffin; S R Harapat; Y G Yee; D C Harrison
Journal:  J Chromatogr       Date:  1977-08-01

2.  Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.

Authors:  A J WOOD
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

3.  Acebutolol saliva excretion.

Authors:  J F Giudicelli; J L Freslon; C Richer
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

4.  CSF plasma ratios of propranolol and pindolol in man [proceedings].

Authors:  E A Taylor; D Carroll; D Jefferson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

5.  Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.

Authors:  P F Meffin; S R Harapat; D C Harrison
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-09

6.  Blood plasma binding of acebutolol and diacetolol in man.

Authors:  T J Coombs; C J Coulson; V J Smith
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335
  6 in total
  3 in total

Review 1.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

Review 2.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

Review 3.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.